Skip to content
zameds

Atomexetine (Atteze)

Atomexetine

Adcock ingram limited

Every registration of this product has been cancelled.

Registration

Applicant
Adcock ingram limited
Registrations
5

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Atteze 10

EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 10,0 mg

1051104451/1.2/1044.1038CancelledNot determinedNone
Atteze 18

EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 18,0 mg

1851104551/1.2/1045.1039CancelledNot determinedNone
Atteze 25

EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 25,0 mg

2551104651/1.2/1046.1040CancelledNot determinedNone
Atteze 40

EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 40,0 mg

4051104751/1.2/1047.1041CancelledNot determinedNone
Atteze 60

EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 10,0 mg

6051104851/1.2/1048.1042CancelledNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

No structure available

This product's active ingredient could not be matched to a single known compound.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles